Strategic Blueprint, LLC
- SEC CIK
- 0001767821
- Latest filing
- Jul 23, 2026
CBAY holding history
CymaBay Therapeutics, Inc. in every 13F filed by Strategic Blueprint, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CBAY overviewAll 13F holders of CBAYFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −15,800−100.0% | Sold out | Holders |
| Q4 2023 | 15,800 | $373.2K | <0.1% | −1,000−6.0% | Reduced | Holders |
| Q3 2023 | 16,800 | $250.5K | <0.1% | +1,000+6.3% | Added | Holders |
| Q2 2023 | 15,800 | $173.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 15,800 | $137.8K | <0.1% | −2,400−13.2% | Reduced | Holders |
| Q4 2022 | 18,200 | $114.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 18,200 | $64.0K | <0.1% | +18,200 | New | Holders |